Skip to content

Participate in our active studies Subscribe to our Mailing List

AB Science

Masitinib and AB8939 – Two compounds with breakthrough mechanism of action

Home
Company
Science
Pipeline
News and Media
Investors
Masivet®
- About Masivet®
- Medical information and Pharmacovigilance
Careers
Contact

Search:

Home
Company
Science
Pipeline
News and Media
Investors
Masivet®
- About Masivet®
- Medical information and Pharmacovigilance
Careers
Contact

June 14 2019 web conference presentation

You are here:

Home
News
2019
June 14 2019 web conference…

14/06/2019 – AB Science web conference presentation

Post navigation

PreviousPrevious post:Positive IDMC recommendation following interim analysis in pancreatic cancer NextNext post:Results of interim analysis for masitinib in Alzheimer’s Disease

Related Posts

Publication of new results in in the peer-reviewed journal Glia that further support masitinib’s potential mode of action in ALS
December 23, 2019

Publication of three AB8939 scientific abstracts in the special ASH Annual Meeting issue of Blood
December 9, 2019

Webcast on masitinib in severe asthma on Monday, December 2, 2019
November 26, 2019

Summary of webcast with Key Opinion Leaders on Indolent Systemic Mastocytosis
November 25, 2019

Clarification regarding the article in the newspaper Les Echos related to the investigation by the French market authorities
November 22, 2019

Positive top-line Phase 3 results for masitinib in severe asthma
November 7, 2019

Search

Search:

Recent Posts

AB Science announces that Health Canada has granted eligibility for reconsideration request for masitinib in ALS
New research shows that masitinib limits neuronal damage in a model of neuroimmune-driven neurodegenerative disease
Summary of the live webcast held on March 4, 2024, providing an update on AB Science development
Two financial analysis firms initiate coverage of AB Science
AB Science webcast of March 4, 2024
Live webcast on Monday March 4, 2024, from 6.30pm to 7.30pm CET

AB SCIENCE
HEADQUARTER

3, Avenue George V – 75008 PARIS – FRANCE
Tel. : +33 (0)1 47 20 00 14
Fax. : +33 (0)1 47 20 24 11

GENERAL INQUIRIES

contact@ab-science.com

PRODUCT INQUIRIES

masivet@ab-science.com

JOB INQUIRIES

careers@ab-science.com

CLINICAL INQUIRIES

clinical@ab-science.com

MEDIA / FINANCIAL INQUIRIES

investors@ab-science.com

PHARMACOVIGILANCE

pharmacovigilance@ab-science.com
Fax : +33 1 47 20 10 82

© AB Science – All right reserved